Aprea Therapeutics (APRE) Q3 2024 Earnings

Aug 12Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1.16
-0.97
-0.77
-0.58

Details

Expected EPS
-0.616333
Actual EPS
-0.58
Surprise EPS
0.04
Surprise Percent
+5.9%

Description

⁨Aprea Therapeutics⁩ (⁦APRE⁩) has reported earnings of ⁦-0.58⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts